Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 4Active not recruiting 3Completed 2Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Breast Neoplasms 80Neoplasms 61Colorectal Neoplasms 42Prostatic Neoplasms 41Carcinoma, Non-Small-Cell Lung 35Lung Neoplasms 31Multiple Myeloma 23Leukemia, Myeloid, Acute 23Head and Neck Neoplasms 22Pancreatic Neoplasms 15Melanoma 15Squamous Cell Carcinoma of Head and Neck 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Ovarian Neoplasms 14Neoplasm Metastasis 14Carcinoma, Hepatocellular 14Recurrence 13Lymphoma, Non-Hodgkin 13Stomach Neoplasms 12Colonic Neoplasms 11Uterine Cervical Neoplasms 10Rectal Neoplasms 10Lymphoma 10Esophageal Neoplasms 10Carcinoma, Renal Cell 10Brain Neoplasms 10Motor Activity 9Kidney Neoplasms 9Myelodysplastic Syndromes 8Lymphoma, Large B-Cell, Diffuse 8

Interventions

lazertinib 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Paclitaxel 1Metformin 1Gefitinib 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Adenocarcinoma of Lung × 30 days × Clear all
NCT04248829 2026-05-28

Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)

Yuhan Corporation

Phase 3 Completed
393 enrolled 13 charts
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT02186847 2026-05-22

Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer

NRG Oncology

Phase 2 Completed
170 enrolled 19 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡